Delta Diagnostics: biosensors are going to save lives worldwide
Delta Diagnostics is at an advanced stage in the development of a platform with which various diagnostic tests can be developed. Such a test consists of a small device that can analyse a drop of blood to determine whether someone has an infectious disease or has had a heart attack.
Learn more about Delta Diagnostics
Now that optical and biological experts have demonstrated the workings of the method in the laboratory, it is a matter of manufacturing a device that must be compact, light and affordable.
This involves point-of-care (PoC) diagnostics, in which a simple device can be used for all kinds of applications at home or at the GP surgery. This is based on the knowledge TNO has developed to detect biomarkers, i.e. proteins that at certain concentrations in the blood indicate specific diseases or disorders.
Prototypes have already been realized that are currently being validated for various applications. In the end it has to be a small, light box in which you place a disposable sensor cartridge with a drop of blood. Optical sensors register within a few minutes what protein concentrations are in the blood for a diagnosis. That is one application, but the biosensor can also detect a series of biomarkers at the same time.
Array of applications
There are multiple applications. In acute situations, a doctor or ambulance worker who has been called to help can immediately determine whether a person is having a heart attack or stroke and act on it quickly. For example, in screening applications, cancer can be diagnosed early. The biosensor is also a solution in remote areas where there is no clinical lab or even electricity is lacking.
Delta Diagnostics was founded by TNO in 2018 and will take the device from the lab to production.
ENGAGE: Patient-driven technology for better insight into disease
The newly formed ENGAGE consortium brings together partners from the entire healthcare ecosystem to develop and implement technological solutions that help people with Type 2 Diabetes address meaningful aspects of their health.
Patient Centric Measurements & Trials
Ease of access, compliance with all legal and privacy regulations, and true relevance for patients and healthcare professionals are important prerequisites for its seamless adoption. TNO offers a one-stop shop for developing innovative ways to measure health, such as digital biomarkers, that put patients first.
Time setters: reduce long waits for new medication with AMS
In this episode, we talk to time setter Wouter Vaes, researcher in microdosing and microtracer studies, about using AMS technology to speed up the development time of new drugs by years.
Health Data Management & Modelling
Data is at the heart of a patient-centric, preventative and digital healthcare future. However, collecting, processing and utilising these data is complex. TNO plays a central role in bringing stakeholders in public health and healthcare together to develop robust, secure and effective Health Data Ecosystems that can address these challenges and optimally use data to improve patient care.
Ancora Health develops personal diabetes plan with 360 methodology
With the help of TNO's knowledge of diabetic typing, Ancora Health wants to implement a diabetes lifestyle programme within healthcare.